Celularity (CELU) Gross Margin (2020 - 2025)
Celularity's (CELU) quarterly Gross Margin came in at 79.68% in Q4 2025, up 88762.0% year-over-year from N/an in Q4 2024, and down 405.09% quarter-over-quarter from 26.12% in Q3 2025.
Powered by 
Analysis
Celularity (CELU) Gross Margin (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Gross Margin for 6 consecutive years, with 79.68% the latest figure, recorded in Q4 2025.
- On a quarterly basis, Gross Margin rose 88762.0% year-over-year to 79.68% in Q4 2025; TTM through Dec 2025 was 24.39%, a 3485.0% decrease from a year earlier, with the FY2025 full-year figure at 24.39%, down 4796.0% from the prior year.
- Gross Margin was 79.68% for Q4 2025 at Celularity, down from 26.12% in the prior quarter.
- Over five years, Gross Margin peaked at 91.31% in Q3 2021 and troughed at 967.3% in Q4 2024.
- A 5-year average of 8.83% and a median of 57.18% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 98796 bps in 2024 and surged 88762 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 70.53% in 2021, then sank by 102 bps to 1.26% in 2022, then surged by 1741 bps to 20.67% in 2023, then tumbled by 4781 bps to 967.3% in 2024, then surged by 92 bps to 79.68% in 2025.
- The last three Gross Margin figures came in at 79.68% (Q4 2025), 26.12% (Q3 2025), and 8.61% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 94.60% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 56.10% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 64.90% |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 94.01% |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 94.90% |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 62.77% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 72.82% |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | -79.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -79.68% |
| Sep 30, 2025 | 26.12% |
| Jun 30, 2025 | 8.61% |
| Mar 31, 2025 | 68.90% |
| Dec 31, 2024 | -967.30% |
| Sep 30, 2024 | 58.23% |
| Jun 30, 2024 | 82.47% |
| Mar 31, 2024 | 88.83% |
| Dec 31, 2023 | 20.67% |
| Sep 30, 2023 | 4.86% |
| Jun 30, 2023 | 72.70% |
| Mar 31, 2023 | 49.10% |
| Dec 31, 2022 | -1.26% |
| Sep 30, 2022 | -33.06% |
| Jun 30, 2022 | 60.57% |
| Mar 31, 2022 | 56.12% |
| Dec 31, 2021 | 70.53% |
| Sep 30, 2021 | 91.31% |
| Jun 30, 2021 | 72.82% |
| Mar 31, 2021 | 72.78% |